Ichikawa T - Search Results

1

Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.

Fujiwara H, Emi M, Nagai H, Nishimura T, Konishi N, Kubota Y, Ichikawa T, Takahashi S, Shuin T, Habuchi T, Ogawa O, Inoue K, Skolnick MH, Swensen J, Camp NJ, Tavtigian SV. Fujiwara H, et al. Among authors: ichikawa t. J Hum Genet. 2002;47(12):641-8. doi: 10.1007/s100380200099. J Hum Genet. 2002. PMID: 12522685

2

Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer.

Shioji G, Ezura Y, Nakajima T, Ohgaki K, Fujiwara H, Kubota Y, Ichikawa T, Inoue K, Shuin T, Habuchi T, Ogawa O, Nishimura T, Emi M. Shioji G, et al. Among authors: ichikawa t. J Hum Genet. 2005;50(10):507-515. doi: 10.1007/s10038-005-0285-1. Epub 2005 Sep 20. J Hum Genet. 2005. PMID: 16172807

3

Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.

Tsuchiya N, Wang L, Suzuki H, Segawa T, Fukuda H, Narita S, Shimbo M, Kamoto T, Mitsumori K, Ichikawa T, Ogawa O, Nakamura A, Habuchi T. Tsuchiya N, et al. Among authors: ichikawa t. J Clin Oncol. 2006 May 1;24(13):1982-9. doi: 10.1200/JCO.2005.02.9439. J Clin Oncol. 2006. PMID: 16648498

4

Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer.

Miyoshi Y, Uemura H, Umemoto S, Sakamaki K, Taguri M, Suzuki K, Shibata Y, Masumori N, Ichikawa T, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S, Harada M, Kubota Y. Miyoshi Y, et al. Among authors: ichikawa t. Prostate. 2016 Mar;76(4):376-82. doi: 10.1002/pros.23129. Epub 2015 Nov 30. Prostate. 2016. PMID: 26616365

5

Clinical characteristics of prostate cancer in elderly Japanese patients 80 years of age or older.

Suzuki H, Akakura K, Ueda T, Mikami K, Tobe T, Komiya A, Ichikawa T, Igarashi T, Ito H. Suzuki H, et al. Among authors: ichikawa t. Eur Urol. 2002 Feb;41(2):172-7. doi: 10.1016/s0302-2838(01)00036-7. Eur Urol. 2002. PMID: 12074405 Clinical Trial.

6

Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.

Fukatsu T, Hirokawa Y, Araki T, Hioki T, Murata T, Suzuki H, Ichikawa T, Tsukino H, Qiu D, Katoh T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M. Fukatsu T, et al. Among authors: ichikawa t. Anticancer Res. 2004 Jul-Aug;24(4):2431-7. Anticancer Res. 2004. PMID: 15330195 Free article.

7

A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M, Hirano D, Takimoto Y, Kamoto T, Ogawa O, Sumiyoshi Y, Shimazaki J, Kakizoe T; Japanese Study Group for Locally Advanced Prostate Cancer. Akakura K, et al. Among authors: ichikawa t. Jpn J Clin Oncol. 2006 Dec;36(12):789-93. doi: 10.1093/jjco/hyl115. Epub 2006 Nov 2. Jpn J Clin Oncol. 2006. PMID: 17082219 Clinical Trial.

8

Evaluation of 2,590 urological laparoscopic surgeries undertaken by urological surgeons accredited by an endoscopic surgical skill qualification system in urological laparoscopy in Japan.

Habuchi T, Terachi T, Mimata H, Kondo Y, Kanayama H, Ichikawa T, Nutahara K, Miki T, Ono Y, Baba S, Naito S, Matsuda T. Habuchi T, et al. Among authors: ichikawa t. Surg Endosc. 2012 Jun;26(6):1656-63. doi: 10.1007/s00464-011-2088-0. Epub 2011 Dec 17. Surg Endosc. 2012. PMID: 22179473

9

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N. Fuse M, et al. Among authors: ichikawa t. J Hum Genet. 2012 Nov 26;57(11):691-9. doi: 10.1038/jhg.2012.95. Epub 2012 Aug 2. J Hum Genet. 2012. PMID: 22854542

10

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.

Miyoshi Y, Uemura H, Umemoto S, Sakamaki K, Morita S, Suzuki K, Shibata Y, Masumori N, Ichikawa T, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S, Harada M, Kubota Y. Miyoshi Y, et al. Among authors: ichikawa t. BMC Cancer. 2014 Sep 26;14:717. doi: 10.1186/1471-2407-14-717. BMC Cancer. 2014. PMID: 25256077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,618 results

Search Page